Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers
Sverre E. Kjeldsen, Krzysztof Narkiewicz, Michel Burnier, Suzanne Oparil
Abstract
From the beginning of the pandemic hypertension appeared as one of the most common comorbidities in patients hospitalised with a Covid-19 infection. Hypertension, diabetes, overweight, chronic pulm...
Topics & Concepts
MedicinePandemicCoronavirus disease 2019 (COVID-19)Angiotensin Receptor BlockersRenin–angiotensin systemDiabetes mellitusBETA (programming language)Internal medicineAdrenergic beta-AntagonistsSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Adrenergic receptorCardiologyReceptorEndocrinologyBlood pressureDiseasePropranololComputer scienceInfectious disease (medical specialty)Programming languageHeart Rate Variability and Autonomic ControlCOVID-19 Clinical Research StudiesBlood Pressure and Hypertension Studies